Patents by Inventor Peter Thraves

Peter Thraves has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prostate cell lines
    Patent number: 7303911
    Abstract: An increasingly aged population and better diagnosis has lead to an apparent increase in the prevalence of prostate cancer in men. There is an acute need to better understand the progression of this disease from its locally confined site of initiation to the end stage widely metastatic disease with attendant morbidity and mortality, It has historically been difficult to raise and maintain immortalized prostate cell lines in culture. We have derived a cell line selected from the group consisting of clones ONYCAP 1 and ONYCAP23. The cell lines are characterized as being prostate epithelial in origin.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: December 4, 2007
    Assignee: Onyvax Limited
    Inventors: Peter Thraves, Andrew Sutton
  • Prostate cell lines
    Publication number: 20030185808
    Abstract: An increasingly aged population and better diagnosis has lead to an apparent increase in the prevalence of prostate cancer in men. There is an acute need to better understand the progression of this disease from its locally confined site of initiation to the end stage widely metastatic disease with attendant morbidity and mortality. It has historically been difficult to raise and maintain immortalised prostate cell lines in culture. We have derived a cell line selected from the group consisting of clones ONYCAP 1 and ONYCAP23. The cell lines arc characterised as being prostate epithelial in origin.
    Type: Application
    Filed: October 23, 2002
    Publication date: October 2, 2003
    Inventors: Peter Thraves, Andrew Sutton